Epicutaneous Application of CpG Oligodeoxynucleotides with Peptide or Protein Antigen Promotes the Generation of CTL

Authors: Klimuk, Sandra K.1; Najar, Hossain M.2; Semple, Sean C.1; Aslanian, Soudabeh2; Dutz, Jan P.2

Source: Journal of Investigative Dermatology, Volume 122, Number 4, April 2004 , pp. 1042-1049(8)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

The full text article is not available for purchase.

The publisher only permits individual articles to be downloaded by subscribers.

Abstract:

Immunostimulatory oligodeoxynucleotides (ODN) are effective adjuvants in the induction of humoral and cellular immune responses when administered parenterally with antigen. The skin has recently become a target organ for the design of non-invasive vaccine technologies. Using ovalbumin (OVA) as a model antigen, we demonstrate that the application of ODN sequences to tape-stripped skin promotes the induction of potent cytotoxic T lymphocyte (CTL) responses to co-administered peptide. Induction of peptide-specific CTL required the presence of CpG motifs within the ODN. CTL afforded tumor protection against a tumor expressing an immunodominant OVA CTL epitope. CTL could also be induced to whole protein administered onto the skin. Differential CpG sequence activity was noted with respect to the induction of CTL to epicutaneous protein with an ODN sequence containing a poly-G motif having an optimal effect. Peptide-specific CTL could be detected in the peripheral blood as early as 6 d after a single immunization. These results highlight the potential of the bare skin as a route for vaccine development and indicate an important role for immunostimulatory ODN as adjuvants to generate functional CTL with the help of the skin immune system.

Keywords: adjuvant; CTL; oligodeoxynucleotides; skin; tumor

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.0022-202X.2004.22411.x

Affiliations: 1: Inex Pharmaceuticals Corporation, Burnaby, British Columbia, Canada; 2: Departments of Medicine and BC Research Institute of Children and Women's Health, University of British Columbia, Vancouver, British Columbia, Canada

Publication date: 2004-04-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page